name:-0.010123014450073
name:-0.015014171600342
name:-0.00050997734069824
Bryant; Joseph Patent Filings

Bryant; Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bryant; Joseph.The latest application filed is for "agent containing flavonoid derivatives for treating cancer and inflammation".

Company Profile
0.17.9
  • Bryant; Joseph - Baltimore MD US
  • Bryant; Joseph - Rockville MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Agent containing flavonoid derivatives for treating cancer and inflammation
Grant 10,765,660 - Lowe , et al. Sep
2020-09-08
Agent Containing Flavonoid Derivatives For Treating Cancer And Inflammation
App 20170360744 - Lowe; Henry ;   et al.
2017-12-21
Methods for inhibiting HIV-1 activity by inhibitory mechanisms of extracts of Guaiacum officinale L. (zygophyllaceae)
Grant 9,814,747 - Lowe , et al. November 14, 2
2017-11-14
Agent containing flavonoid derivatives for treating cancer and inflammation
Grant 9,687,469 - Lowe , et al. June 27, 2
2017-06-27
Methods For Inhibiting Hiv-1 Activity By Inhibitory Mechanisms Of Extracts Of Guaiacum Officinale L. (zygophyllaceae)
App 20170020940 - Lowe; Henry ;   et al.
2017-01-26
Agent Containing Flavonoid Derivatives For Treating Cancer And Inflammation
App 20160145230 - Lowe; Henry ;   et al.
2016-05-26
Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
Grant 9,175,077 - Gallo , et al. November 3, 2
2015-11-03
Nucleic Acids Encoding Biologically Active Polypeptides Derived From A Novel Early Stage Pregnancy Factor Designated Maternin (ma)
App 20140148582 - Gallo; Robert C. ;   et al.
2014-05-29
Biologically Active Polypeptides Derived From A Novel Early Stage Pregnancy Factor Designated Maternin (ma)
App 20120083587 - Gallo; Robert C. ;   et al.
2012-04-05
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
Grant 7,994,278 - Gallo , et al. August 9, 2
2011-08-09
Therapeutic fractions of sources of HCG
Grant 6,805,882 - Gallo , et al. October 19, 2
2004-10-19
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
Grant 6,699,656 - Gallo , et al. March 2, 2
2004-03-02
Method for treating cancer
Grant 6,699,834 - Gallo , et al. March 2, 2
2004-03-02
Method for treating HIV
Grant 6,620,416 - Gallo , et al. September 16, 2
2003-09-16
Method for promoting hematopoiesis
Grant 6,596,688 - Gallo , et al. July 22, 2
2003-07-22
Therapeutic polypeptides from .beta.-hCG and derivatives
Grant 6,583,109 - Gallo , et al. June 24, 2
2003-06-24
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
App 20030049273 - Gallo, Robert C. ;   et al.
2003-03-13
Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
Grant 5,997,871 - Gallo , et al. December 7, 1
1999-12-07
Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
Grant 5,968,513 - Gallo , et al. October 19, 1
1999-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed